These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20438589)

  • 21. Re: Keqin z, et al. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement (Urology 2007;70:1096-1099).
    Chung SD; Chiu B; Yu HJ
    Urology; 2009 Jan; 73(1):216. PubMed ID: 19111744
    [No Abstract]   [Full Text] [Related]  

  • 22. Modelized analysis of pressure-flow studies of patients with lower urinary tract symptoms due to benign prostatic enlargement.
    Valentini FA; Zimmern PE; Besson GR; Nelson PP
    Neurourol Urodyn; 2003; 22(1):45-53. PubMed ID: 12478601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on the change of bladder wall weight pre and after surgery in patients with benign prostatic hyperplasia].
    Li HZ; Zhang XB; Li JC; Xiao H; Huang ZM
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):954-6. PubMed ID: 17961378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of non-invasive urodynamics with International Prostate Symptom Score (IPSS) and prostate volume.
    Huang Foen Chung JW; van Mastrigt R
    Neurourol Urodyn; 2005; 24(1):25-30. PubMed ID: 15468279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A urodynamic study of detrusor hyperreflexia in benign prostatic hypertrophy].
    Murayama K; Katsumi T
    Hinyokika Kiyo; 1987 Mar; 33(3):375-9. PubMed ID: 2441580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urodynamics studies in benign prostatic hypertrophy.
    Schoenberg HW; Gutrich JM; Cote R
    Urology; 1979 Dec; 14(6):634-7. PubMed ID: 92840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of intravesical prostatic protrusion in the management of benign prostatic enlargement: a systematic review and critical analysis of current evidence.
    Rieken M; Presicce F; Autorino R; DE Nunzio C
    Minerva Urol Nefrol; 2017 Dec; 69(6):548-555. PubMed ID: 28263050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Gerber GS
    Urology; 1996 Nov; 48(5):668-75. PubMed ID: 8911507
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical evaluation of isometric detrusor pressure in patients with benign prostatic hyperplasia].
    Nishimoto K
    Hinyokika Kiyo; 1990 Jan; 36(1):19-26. PubMed ID: 1689929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Urodynamic evaluation of aged patients with prostatism].
    Arena G; Laudi M; Novasio R; Fiore L; Sesia G
    Minerva Urol; 1983; 35(4):285-8. PubMed ID: 6201707
    [No Abstract]   [Full Text] [Related]  

  • 31. [Transrectal longitudinal ultrasonography of the prostate by electronic linear scanning (1)].
    Ohnuki T; Kurokawa K; Katoh N; Fukabori Y; Shimizu K; Nakai K; Yamanaka H
    Hinyokika Kiyo; 1987 Sep; 33(9):1385-8. PubMed ID: 3324737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bladder weight and detrusor thickness as parameters of progression of benign prostatic hyperplasia.
    Tubaro A; Mariani S; De Nunzio C; Miano R
    Curr Opin Urol; 2010 Jan; 20(1):37-42. PubMed ID: 19901837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Benign prostatic hyperplasia--an old disease picture--from a new viewpoint].
    Hartung R
    Urologe A; 1995 Mar; 34(2):77-83. PubMed ID: 7538713
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of invasive urodynamic testing in benign prostatic hyperplasia and male lower urinary tract symptoms.
    Mehdizadeh JL; Leach GE
    Urol Clin North Am; 2009 Nov; 36(4):431-41, v. PubMed ID: 19942043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Uroflowmetry measurement in benign prostatic hypertrophy (author's transl)].
    Zhao WP
    Zhonghua Wai Ke Za Zhi; 1980 Mar; 18(3):245-7. PubMed ID: 6162627
    [No Abstract]   [Full Text] [Related]  

  • 37. The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia.
    Brading AF
    Br J Urol; 1994 Jul; 74(1):133. PubMed ID: 7519110
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial comment on: The immediate and 6-mo reproducibility of pressure-flow studies in men with benign prostatic enlargement.
    Meuleman EJ
    Eur Urol; 2007 Oct; 52(4):1193-4. PubMed ID: 17293024
    [No Abstract]   [Full Text] [Related]  

  • 39. A role of intravesical capsaicin instillation in benign prostatic hyperplasia with overactive bladder symptoms: the first reported study in the literature.
    Mahawong P; Chaiyaprasithi B; Soontrapa S; Tappayuthapijarn P
    J Med Assoc Thai; 2007 Sep; 90(9):1821-7. PubMed ID: 17957925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of the reproducibility and applicability of the condom catheter method for noninvasive urodynamics in two Dutch centers.
    Huang Foen Chung JW; Spigt MG; Knottnerus JA; van Mastrigt R
    Urol Int; 2008; 81(2):139-48. PubMed ID: 18758210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.